Related references
Note: Only part of the references are listed.Expression of Toll-Like Receptor 4 in Glomerular Endothelial Cells under Diabetic Conditions
Shunsuke Takata et al.
ACTA HISTOCHEMICA ET CYTOCHEMICA (2013)
Inflammation and the pathogenesis of diabetic nephropathy
Jun Wada et al.
CLINICAL SCIENCE (2013)
Cbl-b Is a Critical Regulator of Macrophage Activation Associated With Obesity-Induced Insulin Resistance in Mice
Tomoki Abe et al.
DIABETES (2013)
Renal Protective Effects of Toll-like Receptor 4 Signaling Blockade in Type 2 Diabetic Mice
J. J. Cha et al.
ENDOCRINOLOGY (2013)
Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2
Thimoteus Speer et al.
IMMUNITY (2013)
ATP-P2X4 signaling mediates NLRP3 inflammasome activation: A novel pathway of diabetic nephropathy
Kehong Chen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis The ACCESS Randomized Trial
Steven M. Opal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
被撤回的出版物: Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin (Retracted article. See vol. 87, pg. 482, 2015)
Fabio Sallustio et al.
KIDNEY INTERNATIONAL (2013)
NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy
Pengchao Du et al.
KIDNEY INTERNATIONAL (2013)
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy
Miao Lin et al.
KIDNEY INTERNATIONAL (2013)
The TLR4 antagonist Eritoran protects mice from lethal influenza infection
Kari Ann Shirey et al.
NATURE (2013)
Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells-Renoprotection in Diabetic Nephropathy?
Usha Panchapakesan et al.
PLOS ONE (2013)
The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules
Harshini Mudaliar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice
T. Kuwabara et al.
DIABETOLOGIA (2012)
Profibrotic Effect of Interleukin-18 in HK-2 Cells Is Dependent on Stimulation of the Toll-like Receptor 4 (TLR4) Promoter and Increased TLR4 Expression
Kirstan K. Meldrum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy
Miao Lin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Serum Amyloid A in Uremic HDL Promotes Inflammation
Thomas Weichhart et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity
Jinu Kim et al.
KIDNEY INTERNATIONAL (2012)
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Durba Pal et al.
NATURE MEDICINE (2012)
Quercetin and Allopurinol Ameliorate Kidney Injury in STZ-Treated Rats with Regulation of Renal NLRP3 Inflammasome Activation and Lipid Accumulation
Chuang Wang et al.
PLOS ONE (2012)
MyD88-Dependent Signaling Influences Fibrosis and Alternative Macrophage Activation during Staphylococcus aureus Biofilm Infection
Mark L. Hanke et al.
PLOS ONE (2012)
Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy
Harmeet Kaur et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Interaction between uric acid and HMGB1 translocation and release from endothelial cells
May M. Rabadi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
The Role of High-Mobility Group Box-1 Protein in the Development of Diabetic Nephropathy
Junghyun Kim et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors
Mohan R. Dasu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Knockout of Toll-Like Receptor-2 Attenuates Both the Proinflammatory State of Diabetes and Incipient Diabetic Nephropathy
Sridevi Devaraj et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Hongting Zheng et al.
DIABETES (2011)
Role of T Cells in Type 2 Diabetic Nephropathy
Chia-Chao Wu et al.
EXPERIMENTAL DIABETES RESEARCH (2011)
DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E-Deficient Mice
Nga N. Ta et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Inhibition of Autoimmune Diabetes by TLR2 Tolerance
Do-Hoon Kim et al.
JOURNAL OF IMMUNOLOGY (2011)
Toll-Like Receptor 4: A Novel Signaling Pathway During Renal Fibrogenesis
Matthew T. Campbell et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury
Jianlin Chen et al.
KIDNEY INTERNATIONAL (2011)
Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4
Jianlin Chen et al.
KIDNEY INTERNATIONAL (2011)
An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes
Sufyan G. Sayyed et al.
KIDNEY INTERNATIONAL (2011)
Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis
Inga Soerensen et al.
KIDNEY INTERNATIONAL (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation
Mehmet Koc et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Pivotal Role of Toll-Like Receptors 2 and 4, Its Adaptor Molecule MyD88, and Inflammasome Complex in Experimental Tubule-Interstitial Nephritis
Matheus Correa-Costa et al.
PLOS ONE (2011)
Rapid Progression of Diabetic Nephropathy Is Linked to Inflammation and Episodes of Acute Renal Failure
K. J. Kelly et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Increased Expression of Toll-Like Receptor 2 in Rat Diabetic Nephropathy
Fanglin Li et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes
Nga N. Ta et al.
ATHEROSCLEROSIS (2010)
HMGB1: the missing link between diabetes mellitus and heart failure
H. Christian Volz et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis
Todd W. Rice et al.
CRITICAL CARE MEDICINE (2010)
TLR signalling regulated antigen presentation in dendritic cells
Colin Watts et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
Dachun Yao et al.
DIABETES (2010)
Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects
Mohan R. Dasu et al.
DIABETES CARE (2010)
TLR2 plays a role in the activation of human resident renal stem/progenitor cells
Fabio Sallustio et al.
FASEB JOURNAL (2010)
Endogenous ligands of TLR2 and TLR4: agonists or assistants?
Clett Erridge
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
TLR4 Promotes Fibrosis but Attenuates Tubular Damage in Progressive Renal Injury
Wilco P. Pulskens et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis
Shaun A. Summers et al.
KIDNEY INTERNATIONAL (2010)
CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice
Young Sun Kang et al.
KIDNEY INTERNATIONAL (2010)
Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands
Xiaoxia Z. West et al.
NATURE (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Targeting Toll-like receptors: emerging therapeutics?
Elizabeth J. Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Fibrinogen That Appears in Bowman's Space of Proteinuric Kidneys in vivo Activates Podocyte Toll-Like Receptors 2 and 4 in vitro
Masaru Motojima et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2010)
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
Huan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Kate Schroder et al.
SCIENCE (2010)
Protective Effects of Toll-like Receptor 4 Inhibitor Eritoran on Renal Ischemia-Reperfusion Injury
M. Liu et al.
TRANSPLANTATION PROCEEDINGS (2010)
Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema
Giorgio Zanotti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Renal tubular expression of Toll-like receptor 4 in cyclosporine nephrotoxicity
Beom Jin Lim et al.
APMIS (2009)
Candesartan attenuates Angiotensin II-induced mesangial cell apoptosis via TLR4/MyD88 pathway
Jinlei Lv et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2
Rong L. He et al.
BLOOD (2009)
Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)
Mark R. Hutchinson et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Responses to Amyloids of Microbial and Host Origin Are Mediated through Toll-like Receptor 2
Cagla Tuekel et al.
CELL HOST & MICROBE (2009)
Macrophages Generate Reactive Oxygen Species in Response to Minimally Oxidized Low-Density Lipoprotein Toll-Like Receptor 4-and Spleen Tyrosine Kinase-Dependent Activation of NADPH Oxidase 2
Yun Soo Bae et al.
CIRCULATION RESEARCH (2009)
Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells
Klara Sochorova et al.
CLINICAL IMMUNOLOGY (2009)
Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes
S. Devaraj et al.
DIABETOLOGIA (2009)
Pioglitazone Inhibits Toll-Like Receptor Expression and Activity in Human Monocytes and db/db Mice
Mohan R. Dasu et al.
ENDOCRINOLOGY (2009)
Identification and characterization of oligonucleotides that inhibit Toll-like receptor 2-associated immune responses
Yi-Chung Chang et al.
FASEB JOURNAL (2009)
Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors
Andrea Babelova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease
Kim Midwood et al.
NATURE MEDICINE (2009)
The Role of Toll-Like Receptor 2 in Inflammation and Fibrosis during Progressive Renal Injury
Jaklien C. Leemans et al.
PLOS ONE (2009)
Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation
Bernd Krueger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
High Glucose Induces Toll-Like Receptor Expression in Human Monocytes Mechanism of Activation
Mohan R. Dasu et al.
DIABETES (2008)
Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects
Sara M. Reyna et al.
DIABETES (2008)
Increased toll-like receptor (TLR)2 and TLR4 expression in monocytes from patients with type 1 diabetes: Further evidence of a proinflammatory state
Sridevi Devaraj et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of β-defensin 2 via TLR2 and TLR4
Silvia Gariboldi et al.
JOURNAL OF IMMUNOLOGY (2008)
Murine β-defensin 2 promotes TLR-4/MyD88-mediated and NF-κB-dependent atypical death of APCs via activation of TNFR2
Arya Biragyn et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Tracking the Toll of Kidney Disease
Anushree C. Shirali et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity
Binzhi Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
TLR4 links podocytes with the innate immune system to mediate glomerular injury
Miriam C. Banas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
The role of inflammatory cytokines in diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
HMGB1: Endogenous danger signaling
John R. Klune et al.
MOLECULAR MEDICINE (2008)
Toll-Like Receptor-4 Coordinates the Innate Immune Response of the Kidney to Renal Ischemia/Reperfusion Injury
Wilco P. Pulskens et al.
PLOS ONE (2008)
A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways
M. T. Audrey Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
TLR4 activation mediates kidney ischemia/reperfusion injury
Huiling Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Mrp8 and Mrp14 are endogenous activators of Toll- like receptor 4, promoting lethal, endotoxin-induced shock
Thomas Vogl et al.
NATURE MEDICINE (2007)
被撤回的出版物: Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance (Retracted article. See vol. 65, pg. 1126, 2016)
Daniela M. L. Tsukumo et al.
DIABETES (2007)
Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity
Francis Kim et al.
CIRCULATION RESEARCH (2007)
C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet
M. Poggi et al.
DIABETOLOGIA (2007)
The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice
Volha Ninichuk et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy
Takahiko Nakagawa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II:: Dependency on AP1 and PU.1 transcriptional sites
Tzvetanka Bondeva et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Siravastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo
Alexander Niessner et al.
ATHEROSCLEROSIS (2006)
How does proteinuria cause progressive renal damage?
Mauro Abbate et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages
Kinga A. Powers et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Oxidized low-density lipoprotein correlates positively with toll-like receptor 2 and interferon regulatory factor-1 and inversely with superoxide dismutase-1 expression -: Studies in hypercholesterolemic swine and THP-1 cells
Paul Holvoet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Angiotensin II upregulates toll-like receptor 4 on mesangial cells
Gunter Wolf et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-γ agonist
Sydney C. W. Tang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4
Rick de Graaf et al.
MICROBES AND INFECTION (2006)
Role of the JAK/STAT signaling pathway in diabetic nephropathy
MB Marrero et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Leukocyte recruitment and vascular injury in diabetic nephropathy
Elena Galkina et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney
JC Leemans et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages
L Schaefer et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes
H Methe et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages
YI Miller et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Protein kinase Cβ inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy
DJ Kelly et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease
MM Fort et al.
JOURNAL OF IMMUNOLOGY (2005)
Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes
I Kokkinopoulos et al.
MOLECULAR IMMUNOLOGY (2005)
Hyaluronan fragments stimulate endothelial recognition of injury through TLR4
KR Taylor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Signaling danger:: Toll-like receptors and their potential roles in kidney disease
HJ Anders et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy
M Toyoda et al.
KIDNEY INTERNATIONAL (2004)
Inferences, questions and possibilities in toll-like receptor signalling
B Beutler
NATURE (2004)
Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis
FY Chow et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
F Chow et al.
KIDNEY INTERNATIONAL (2004)
NF-κB activation and overexpression of regulated genes in human diabetic nephropathy
S Mezzano et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Inhibition of endotoxin response by E5564, a novel toll-like receptor 4-directed endotoxin antagonist
M Mullarkey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells
YI Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2
A Biragyn et al.
SCIENCE (2002)
Cutting edge: The immunostimulatory activity of the lung surfactant protein-A involves toll-like receptor 4
L Guillot et al.
JOURNAL OF IMMUNOLOGY (2002)
The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the toll-like receptor 2/4 pathway
RM Vabulas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4
GB Johnson et al.
JOURNAL OF IMMUNOLOGY (2002)
HSP70 as endogenous stimulus of the toll/interleukin-1 receptor signal pathway
RM Vabulas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
Inhibitory effect of ibudilast on urinary albumin excretion in type 2 diabetes mellitus with microalbuminuria
T Hoshino et al.
NEPHRON (2002)
Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL
XH Xu et al.
CIRCULATION (2001)
Cellular mechanisms in the development and progression of diabetic nephropathy: Activation of the DAG-PKC-ERK pathway
M Haneda et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4
ST Smiley et al.
JOURNAL OF IMMUNOLOGY (2001)
The extra domain A of fibronectin activates toll-like receptor 4
Y Okamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex
K Ohashi et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
